RxDoctor Payments Data

Yvette Alvarez, DO

Family Medicine · Rockport, TXNPI 1528328309

Payments from drug & device makers

$2,405in general payments, 2019–2025

Across 146 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$556
  • Amgen$349
  • GSK$276
  • Pfizer$189
  • Astellas Pharma US Inc$158
  • Novo Nordisk$148
  • plus $728 from 18 others

What the payments were for

  • Food & beverage$2,28495%
  • Education$1225%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,405 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$25,916
Medicare patients
138
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide86$138,036
OzempicSemaglutide74$95,374
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$74,579
EliquisApixaban52$73,852
MyrbetriqMirabegron35$43,914
JardianceEmpagliflozin30$42,442
RybelsusSemaglutide20$41,950
TrulicityDulaglutide32$37,673
XareltoRivaroxaban27$32,085
LinzessLinaclotide17$18,492
FarxigaDapagliflozin Propanediol12$18,389
Breo ElliptaFluticasone/Vilanterol22$15,235
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$12,324
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$12,130
SymbicortBudesonide/Formoterol Fumarate19$11,579

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$556$175,709118 claims
Novo NordiskOzempic, Rybelsus$148$137,32594 claims
GSKTrelegy Ellipta, Breo Ellipta$276$89,81475 claims
PfizerEliquis$189$73,85252 claims
Astellas Pharma US IncMyrbetriq$158$43,91435 claims
Boehringer IngelheimJardiance$15$42,44230 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$105$42,29143 claims
AbbVieLinzess$39$18,49217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Rockport

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →